Clinical Trial Update: Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating disitamab vedotin with sintilimab as first-line treatment in elderly patients with gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Disitamab Vedotin (disitamab vedotin)
• Sintilimab (sintilimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN